Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Downey

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.
Lancet (London, England)|November 5, 2019
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trialHarry G M Heijerman, Edward F McKone, Damian G Downey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2018
Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing ageMichal Shteinberg, Adi Ben Lulu, Damian G Downey, et al.
The Journal of Infectious Diseases|April 18, 2024
Genomic Analysis and Surveillance of Respiratory Syncytial Virus Using Wastewater-Based EpidemiologyDanielle M Allen, Marina I Reyne, Pearce Allingham, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 16, 2024
A clinical consensus guideline for nutrition in infants with congenital diaphragmatic hernia from birth through dischargePatrick Sloan, Sandy Johng, John M Daniel, et al.
The European Respiratory Journal|June 12, 2025
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trialBarry J Plant, Gisli G Einarsson, Kevin F Deasy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial FluidAileen Y Chang, Karen A O Martins, Liliana Encinales, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disordersN J Simmonds, K W Southern, E De Wachter, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2025
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosisNatalie E West, Michael W Konstan, Patrick A Flume, et al.
Lancet (London, England)|November 5, 2019
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trialHarry G M Heijerman, Edward F McKone, Damian G Downey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 28, 2018
Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing ageMichal Shteinberg, Adi Ben Lulu, Damian G Downey, et al.
The Journal of Infectious Diseases|April 18, 2024
Genomic Analysis and Surveillance of Respiratory Syncytial Virus Using Wastewater-Based EpidemiologyDanielle M Allen, Marina I Reyne, Pearce Allingham, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 16, 2024
A clinical consensus guideline for nutrition in infants with congenital diaphragmatic hernia from birth through dischargePatrick Sloan, Sandy Johng, John M Daniel, et al.
The European Respiratory Journal|June 12, 2025
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trialBarry J Plant, Gisli G Einarsson, Kevin F Deasy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial FluidAileen Y Chang, Karen A O Martins, Liliana Encinales, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disordersN J Simmonds, K W Southern, E De Wachter, et al.
Pageof 19